patupilone + prednisone

Patupilone + prednisone is an investigational drug combination composed of patupilone, a synthetic epothilone analog, and prednisone, a synthetic oral glucocorticoid. Patupilone acts primarily as a microtubule stabilizer—similar in mechanism to taxanes—by binding to and stabilizing microtubules, thereby inhibiting their depolymerization and interfering with cell division, which leads to apoptosis in tumor cells. Prednisone is used both for its anti-inflammatory properties and for palliation of symptoms. In cancer therapy combinations, prednisone often serves as a supportive agent to mitigate side effects and enhance therapeutic outcomes, especially in prostate cancer and other hormone-sensitive malignancies. Patupilone has been investigated for several solid tumors, while prednisone is widely used in oncology for immunosuppression and symptom management.